Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetBreCS
2015-001001-14Phase 2Terminated
- Sponsor
- European Institute of Oncology
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Metformin with Placebo (2 arms). Primary endpoint: Change of Ki-67 in contralateral unaffected breast. Started Jan 2021; status: terminated.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-001001-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001001-14.